United States: Life Sciences, Biotechnology & Nanotechnology

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
Ambitious Priorities: Breaking Down FDA’s FY27 Budget
As the Fiscal Year 2027 (FY27) budget and appropriations process kicks into full swing this month, the release of the President’s budget and related congressional hearings provide opportunities to gain insight into both the Trump administration’s and congressional lawmakers’ areas of focus for the Department of Health and Human Services, including the Food and Drug Administration (FDA).
United States Healthcare
AG
Akin Gump Strauss Hauer & Feld LLP
Article
Trust Your Instincts: Susan Pravda On Leadership, Relationships, And Resilience
Foley partner Susan Pravda shares how a relationship-driven approach has shaped her four-decade legal career, from a chance encounter on her first day of practice to her current role leading the firm's Health Care & Life Sciences Sector. She discusses the importance of viewing clients as people rather than entities, being present during pivotal moments, and trusting your instincts when navigating uncertainty.
United States Commercial
FL
Foley & Lardner
Article
Trump Administration Announces Tariffs On Imported Patented Medication And Pharmaceutical Ingredients Under Section 232 Of The Trade Expansion Act Of 1962
On April 2, 2026, exactly one year after the “Liberation Day” tariffs, President Donald Trump issued a Proclamation, “Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients into the United States,” (the “Proclamation”) imposing sweeping tariffs on imported patented medications and active pharmaceutical ingredients (“APIs”).
United States International
MB
Mayer Brown
Article
Benesch Healthcare+ Dialysis & Nephrology Digest No. 74
Benesch's Dialysis & Nephrology Digest provides a comprehensive monthly report on the dialysis and nephrology industry, covering legislative updates, clinical developments, business transactions, and regulatory changes. This April 2026 edition highlights key policy initiatives including ASN's congressional advocacy efforts, CMS's new LEAD ACO model, and updates to the Kidney Care Choices program, alongside significant pharmaceutical advances from Vertex and Bayer in kidney disease treatment.
United States Healthcare
B
Benesch Friedlander Coplan & Aronoff LLP
Article
Federal District Court Blocks Texas AG Ken Paxton From Enforcing Conspicuous Warning Label Requirement For Food Products Containing 44 Listed Ingredients
In 2025, Texas passed Senate Bill 25, which includes a labeling mandate for food products. Section 9 of the Bill adds language to the Texas Health and Safety Code that would require food manufacturers to put conspicuous warning labels on any food product sold in the State that contains any of 44 listed ingredients (subject to some exceptions).
United States Healthcare
SJ
Steptoe LLP
See more

Highlighted Content

Latest Videos

See more